IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling - PubMed (original) (raw)
. 1998 Nov 1;161(9):4611-7.
Affiliations
- PMID: 9794389
IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling
A Banerjee et al. J Immunol. 1998.
Abstract
The mechanism by which early lymphoid cells are selectively transformed by v-Abl is currently unknown. Previous studies have shown constitutive activation of IL-4 and IL-7 signaling pathways, as measured by activation of Janus protein kinase (JAK)1, JAK3, STAT5, and STAT6, in pre-B cells transformed by v-Abl. To determine whether activation of these cytokine signaling pathways by v-Abl is important in the cellular events induced by the Abelson murine leukemia virus, the effects of IL-4 and IL-7 on pre-B cells transformed with a temperature-sensitive v-Abl mutant were examined. Whereas IL-4 had little or no effect, IL-7 delayed both the apoptosis and cell cycle arrest that occur upon v-Abl kinase inactivation. IL-7 also delayed the decreases in the levels of c-Myc, Bcl-2, and Bcl-xL that occur upon loss of v-Abl kinase activity. IL-7 did not maintain v-Abl-mediated differentiation arrest of the pre-B cells, as activation of NF-kappaB and RAG gene transcription was unaffected by IL-7. These results identify a potential role for IL-7 signaling pathways in transformation by v-Abl while demonstrating that a combination of IL-4 and IL-7 signaling cannot substitute for an active v-Abl kinase in transformed pre-B cells.
Similar articles
- Jak-STAT signaling induced by the v-abl oncogene.
Danial NN, Pernis A, Rothman PB. Danial NN, et al. Science. 1995 Sep 29;269(5232):1875-7. doi: 10.1126/science.7569929. Science. 1995. PMID: 7569929 - Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus.
Noronha EJ, Sterling KH, Calame KL. Noronha EJ, et al. J Biol Chem. 2003 Dec 19;278(51):50915-22. doi: 10.1074/jbc.M306629200. Epub 2003 Oct 13. J Biol Chem. 2003. PMID: 14559912 - An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY, Wang LC, Huang MS, Rosenberg N. Chen YY, et al. Genes Dev. 1994 Mar 15;8(6):688-97. doi: 10.1101/gad.8.6.688. Genes Dev. 1994. PMID: 7926759 - JAK-STAT signaling activated by Abl oncogenes.
Danial NN, Rothman P. Danial NN, et al. Oncogene. 2000 May 15;19(21):2523-31. doi: 10.1038/sj.onc.1203484. Oncogene. 2000. PMID: 10851051 Review. - Arrested development: understanding v-abl.
Kerr LD. Kerr LD. Bioessays. 1994 Jul;16(7):453-5. doi: 10.1002/bies.950160702. Bioessays. 1994. PMID: 7945272 Review.
Cited by
- Stepwise activation of the immunoglobulin mu heavy chain gene locus.
Chowdhury D, Sen R. Chowdhury D, et al. EMBO J. 2001 Nov 15;20(22):6394-403. doi: 10.1093/emboj/20.22.6394. EMBO J. 2001. PMID: 11707410 Free PMC article. - Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-kappaB.
Wilson MK, McWhirter SM, Amin RH, Huang D, Schlissel MS. Wilson MK, et al. Mol Cells. 2010 Apr;29(4):333-41. doi: 10.1007/s10059-010-0029-8. Epub 2010 Mar 4. Mol Cells. 2010. PMID: 20213318 Free PMC article. - Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
Gong L, Unnikrishnan I, Raghavan A, Parmar K, Rosenberg N. Gong L, et al. J Virol. 2004 Feb;78(4):1636-44. doi: 10.1128/jvi.78.4.1636-1644.2004. J Virol. 2004. PMID: 14747529 Free PMC article. - BCL6 is critical for the development of a diverse primary B cell repertoire.
Duy C, Yu JJ, Nahar R, Swaminathan S, Kweon SM, Polo JM, Valls E, Klemm L, Shojaee S, Cerchietti L, Schuh W, Jäck HM, Hurtz C, Ramezani-Rad P, Herzog S, Jumaa H, Koeffler HP, de Alborán IM, Melnick AM, Ye BH, Müschen M. Duy C, et al. J Exp Med. 2010 Jun 7;207(6):1209-21. doi: 10.1084/jem.20091299. Epub 2010 May 24. J Exp Med. 2010. PMID: 20498019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous